Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

SkyBridge looks to expansion in Asia with Woori strategic partnership

Thursday, July 11, 2013

Bailey McCann, Opalesque New York:

SkyBridge Capital and Woori Investment & Securities have announced a strategic partnership that will allow for the distribution of SkyBridge’s hedge fund products throughout Korea and other regions in Asia. In conjunction with the partnership, Woori has also allocated capital to a SkyBridge fund of hedge funds vehicle.

"We started looking at Woori over two years ago when we began examining ways to expand the business and wanted to increase the awareness of Skybridge in Asia," Ray Nolte, co-managing partner and chief investment officer at SkyBridge Capital, tells Opalesque.

SkyBridge Capital has approximately $8.2bn in AUM, historically focusing on the US. The firm also has a product available to retail investors. The retail product has approximately $3.9bn in AUM and has added nearly $1bn this year. Woori Investment & Securities is a core subsidiary of the Woori Financial Group, one of the largest financial groups in Korea.

"We made a number of trips out to Asia and recently launched the SkyBridge SALT Conference in Asia. There is some historic skepticism about hedge funds in that part of the world, but we think the corporate structure and governance in Korea is strong and we are starting to build relationships. We are taking a longer term view of the region and believe demand will continue to build for alternatives," Nolte says.

Through this partnership the firm plans to increase global distribution of its hedge fund ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for